Oncolytic virus-based hepatocellular carcinoma treatment: Current status, intravenous delivery strategies, and emerging combination therapeutic solutions

Current treatments for advanced hepatocellular carcinoma (HCC) have limited success in improving patients’ quality of life and prolonging life expectancy. The clinical need for more efficient and safe therapies has contributed to the exploration of emerging strategies. Recently, there has been incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xinguo, Sun, Xiaonan, Wang, Bingyuan, Li, Yiling, Tong, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989663/
https://www.ncbi.nlm.nih.gov/pubmed/36896445
http://dx.doi.org/10.1016/j.ajps.2022.100771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989663/
https://www.ncbi.nlm.nih.gov/pubmed/36896445
http://dx.doi.org/10.1016/j.ajps.2022.100771

Ejemplares similares